Kotak Mahindra MF introduces Nifty Pharma Index Fund
Kotak Mahindra Mutual Fund has launched a new scheme that tracks the Nifty Pharma Index. This is an exchange-traded fund (ETF) that aims to mirror the performance of the top pharmaceutical companies listed on the National Stock Exchange. By investing in this fund, investors gain exposure to a basket of leading drugmakers, allowing them to participate in the sector's growth without having to pick individual stocks.
For investors, this launch offers a convenient way to diversify their portfolio with a sector-focused bet. The Nifty Pharma Index typically includes large-cap companies known for their research and manufacturing capabilities. This move is significant as it expands the range of options available to those looking to allocate capital to the healthcare and drug manufacturing space.
Investors should monitor the fund's expense ratio and the performance of the underlying index. It is also important to consider how this fund fits into your overall asset allocation strategy. Since the pharma sector can be volatile, keeping an eye on regulatory changes and global demand trends will be crucial for long-term investors.
Excerpt from Investment Guru India
IITF 2026: ITPO waives entry fee for senior citizens during business days HDFC AMC announces change in Information on Key Personnel HDFC MF announces IDCW record date under Arbitrage Fund Please click the activation link we sent on your email An email has been sent to your registered email address containing an…Read the original at Investment Guru India
Key takeaways
- Category: Sector.
Why it matters
A routine update. Use the price and stock snapshot to gauge how the market is responding.













